LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc.verified

LMAT

Price:

$94.88

Market Cap:

$2.13B

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid ar...[Read more]

Industry

Medical - Instruments & Supplies

IPO Date

2006-10-19

Stock Exchange

NASDAQ

Ticker

LMAT

The Enterprise Value as of November 2024 (TTM) for LeMaitre Vascular, Inc. (LMAT) is 2.11B

According to LeMaitre Vascular, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.11B. This represents a change of 28.05% compared to the average of 1.65B of the last 4 quarters.

LeMaitre Vascular, Inc. (LMAT) Historical Enterprise Value (quarterly & annually)

How has LMAT Enterprise Value performed in the past?

The mean historical Enterprise Value of LeMaitre Vascular, Inc. over the last ten years is 674.26M. The current 2.11B Enterprise Value has changed 31.25% with respect to the historical average. Over the past ten years (40 quarters), LMAT's Enterprise Value was at its highest in in the September 2024 quarter at 2.07B. The Enterprise Value was at its lowest in in the December 2014 quarter at 114.20M.

Quarterly (TTM)
Annual

Average

674.26M

Median

650.41M

Minimum

108.41M

Maximum

1.26B

LeMaitre Vascular, Inc. (LMAT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of LeMaitre Vascular, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 157.35%

Maximum Annual Enterprise Value = 1.26B

Minimum Annual Increase = -25.95%

Minimum Annual Enterprise Value = 108.41M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20231.26B24.50%
20221.01B-5.26%
20211.06B25.57%
2020847.98M18.40%
2019716.20M65.44%
2018432.91M-25.95%
2017584.62M31.64%
2016444.12M59.20%
2015278.98M157.35%
2014108.41M0.40%

LeMaitre Vascular, Inc. (LMAT) Average Enterprise Value

How has LMAT Enterprise Value performed in the past?

The current Enterprise Value of LeMaitre Vascular, Inc. (LMAT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

1.11B

5-year avg

978.72M

10-year avg

674.26M

LeMaitre Vascular, Inc. (LMAT) Enterprise Value vs. Peers

How is LMAT’s Enterprise Value compared to its peers?

LeMaitre Vascular, Inc.’s Enterprise Value is greater than InfuSystem Holdings, Inc. (175.22M), greater than Pro-Dex, Inc. (134.21M), greater than Utah Medical Products, Inc. (222.85M), greater than Milestone Scientific Inc. (57.50M), less than Hologic, Inc. (0), less than Haemonetics Corporation (19.24B), less than ICU Medical, Inc. (4.54B), less than Envista Holdings Corporation (5.55B), less than The Cooper Companies, Inc. (4.03B), less than Becton, Dickinson and Company (23.60B), less than KORU Medical Systems, Inc. (82.83B), greater than Atrion Corporation (117.32M), greater than null (797.97M),

Build a custom stock screener for LeMaitre Vascular, Inc. (LMAT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LeMaitre Vascular, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

LeMaitre Vascular, Inc. (LMAT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like LeMaitre Vascular, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is LeMaitre Vascular, Inc.'s Enterprise Value?

What is the highest Enterprise Value for LeMaitre Vascular, Inc. (LMAT)?

What is the 3-year average Enterprise Value for LeMaitre Vascular, Inc. (LMAT)?

What is the 5-year average Enterprise Value for LeMaitre Vascular, Inc. (LMAT)?

How does the current Enterprise Value for LeMaitre Vascular, Inc. (LMAT) compare to its historical average?